Kelsey A. Woodruff

This study identifies Dfm1 as a key factor in Ste24-dependent translocon quality control, showing that its loss increases toxicity of clogged translocon substrates.

This study shows CD45-targeted astatine-211 radioimmunotherapy more severely impairs hematopoietic recovery and reprograms bone marrow endothelial cells compared to non-targeted radiation.

This study shows that syndecan-2 in mesenchymal stromal cells, but not endothelial cells, supports HSC self-renewal and cytokine responses by modulating growth factor signaling.